Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic …
JD Abbott, MR Voss, M Nakamura, HA Cohen… - Journal of the American …, 2007 - jacc.org
Objectives: We investigated the effectiveness and safety of drug-eluting stents (DES) as
used in routine clinical practice. Background: Randomized trials have shown that DES …
used in routine clinical practice. Background: Randomized trials have shown that DES …
Sirolimus-eluting coronary stents: a review
A Abizaid - Vascular health and risk management, 2007 - Taylor & Francis
The sirolimus-eluting coronary stent received CE Mark approval in Europe in April 2002. In
the US, FDA approval followed in April 2003. Since the preliminary results from the First-in …
the US, FDA approval followed in April 2003. Since the preliminary results from the First-in …
The PASEO (paclitaxel or sirolimus-eluting stent versus bare metal stent in primary angioplasty) randomized trial
E Di Lorenzo, G De Luca, R Sauro, A Varricchio… - JACC: Cardiovascular …, 2009 - jacc.org
Objectives: The aim of this study was to evaluate the benefits of sirolimus-eluting stents
(SES) and paclitaxel-eluting stents (PES) as compared with bare-metal stents (BMS) in …
(SES) and paclitaxel-eluting stents (PES) as compared with bare-metal stents (BMS) in …
Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up
H Roukoz, AA Bavry, ML Sarkees, GR Mood… - The American journal of …, 2009 - Elsevier
BACKGROUND: Several observational reports have documented both increased and
decreased cardiac mortality or Q-wave myocardial infarction with drug-eluting stents …
decreased cardiac mortality or Q-wave myocardial infarction with drug-eluting stents …
Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the …
A Kaltoft, H Kelbæk, L Thuesen, JF Lassen… - Journal of the American …, 2010 - jacc.org
Objectives: The purpose of this study was to compare long-term clinical outcomes after
implantation of drug-eluting stents (DES) and bare-metal stents (BMS) in patients with ST …
implantation of drug-eluting stents (DES) and bare-metal stents (BMS) in patients with ST …
The REMEDEE-OCT study: an evaluation of the bioengineered COMBO dual-therapy CD34 antibody–covered sirolimus-eluting coronary stent compared with a cobalt …
M Jaguszewski, R Aloysius, W Wang… - JACC: Cardiovascular …, 2017 - jacc.org
Objectives: The aim of the present study was to evaluate vascular healing of the
bioengineered COMBO Dual Therapy Stent compared with a cobalt-chromium (CoCr) …
bioengineered COMBO Dual Therapy Stent compared with a cobalt-chromium (CoCr) …
Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with …
M Valgimigli, G Campo, C Arcozzi, P Malagutti… - Journal of the American …, 2007 - jacc.org
Objectives: We sought to investigate whether the previously reported midterm clinical benefit
of planned sirolimus-eluting stent (SES) implantation in patients with ST-segment elevation …
of planned sirolimus-eluting stent (SES) implantation in patients with ST-segment elevation …
Risk factors for in-stent restenosis after vertebral ostium stenting
RA Taylor, F Siddiq, MFK Suri… - Journal of …, 2008 - journals.sagepub.com
Purpose: To determine whether vascular risk factors, underlying vessel diameter, and/or the
type of stent affect restenosis rates for vertebral ostium stents. Methods: A single-center …
type of stent affect restenosis rates for vertebral ostium stents. Methods: A single-center …
Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the …
G Guagliumi, V Sirbu, H Bezerra… - JACC: Cardiovascular …, 2010 - jacc.org
Objectives: Using optical coherence tomography, we assessed the proportion of uncovered
struts at 6-month follow-up in zotarolimus-eluting stents (ZES), specifically Endeavor …
struts at 6-month follow-up in zotarolimus-eluting stents (ZES), specifically Endeavor …
Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e …
P Urban, A Abizaid, A Banning, AL Bartorelli… - Journal of the American …, 2011 - jacc.org
Objectives: The aim of this study was to ascertain the 1-year incidence of stent thrombosis
(ST) and major bleeding (MB) in a large, unselected population treated with sirolimus …
(ST) and major bleeding (MB) in a large, unselected population treated with sirolimus …